You just read:

QRxPharma Granted Target Date for FDA Action on MoxDuo® IR NDA: NDA Accepted for Review; PDUFA Date Set for June 25, 2012

News provided by

QRxPharma Limited

Nov 08, 2011, 08:45 ET